Angiotensin II in vasodilatory shock: lights and shadows
Angiotensin II in vasodilatory shock: lights and shadows
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Recently, an international randomized controlled trial (ATHOS-3) [1] has shown that Ang II can induce a significant increase in mean arterial pressure (MAP) if compared to placebo. [...]during the first 48 hours from the randomization, doses of the vasopressors (norepinephrine (NE) and vasopressin) were significantly reduced in the Ang II group but...
Alternative Titles
Full title
Angiotensin II in vasodilatory shock: lights and shadows
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5d665ca1b51547cc901e189edbd7b233
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5d665ca1b51547cc901e189edbd7b233
Other Identifiers
ISSN
1364-8535
E-ISSN
1466-609X,1364-8535,1366-609X
DOI
10.1186/s13054-017-1869-9
